BIG Thinking

Ideas worth sharing. Conversations worth joining.

Perspectives from JFK on the science, business and communications issues shaping life sciences — through original commentary, published articles, podcasts, media appearances and conversations across the industry.

Antibody-drug conjugates engaging breast-cancer tumor cells

Featured Thinking

Metastatic Breast Cancer: The Treatment Advances Are Real. So Is the Unmet Need.

August 14, 2026

John F. Kouten

Targeted therapies, ADCs and immunotherapies have given patients more options. For metastatic disease, more options is still not the same as a cure.

Start-Up Life Science Dilemma: To PR or Not to PR?

Five questions to answer before you engage an agency — and the four foundational pillars that make PR work once you do.

Cancer Patient Journey: Are We Going in the Right Direction?

“Partnering with Patients” was the ASCO theme. What the sessions revealed about equity, access and the clinician-patient relationship.

Maximize Your Media Monitoring

The report is not the thing. If you cannot translate monitoring into strategic action, it is useless and costly.

Read the article

PR Strategy

August 10, 2023

John F. Kouten

Start-Up Life Science Dilemma: To PR or Not to PR?

Five questions to answer before you engage an agency — and the four foundational pillars that make PR work once you do.

Cancer Patient Journey: Are We Going in the Right Direction?

“Partnering with Patients” was the ASCO theme. What the sessions revealed about equity, access and the clinician-patient relationship.

Maximize Your Media Monitoring

The report is not the thing. If you cannot translate monitoring into strategic action, it is useless and costly.

Read the article

Got something BIG to share?

A breakthrough. A milestone. A challenge. An idea that deserves more attention. Tell us what’s next.

Ask a BIG Question